by The global neurovascular devices market size is projected to reach from US$ 2.7 billion in 2021 to US$ 4.52 billion by 2030, growing at a CAGR of 5.7% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.
The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030. The neurovascular devices market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit). The report offers exclusive insights to help companies make informed decisions to sustain growth through the assessment period.
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1391
The global neurovascular devices are primarily driven by the rising incidences of neurological disorders such as strokes, epilepsy, and cerebral aneurysm among the population. Moreover, the growing geriatric population is further estimated to drive the growth of the market in the forthcoming years.
As per the National Center for Biotechnology Information, strokes are common in women and are frequent in those aged 55 years to 65 years. According to the Unite Nations, there were around 382 million old age people, aged 60 years or above, across the globe in 2017 ad this number is expected 2.1 billion by 2050. The various technological advancements and new product launches are positively impacting the market. For instance, in October 2020, the BENDIT Technologies, in Israel, successfully developed the new BENDIT neuro micro-catheter.
Report Scope of the Neurovascular Devices Market
| Report Highlights | Details |
| Market Size | USD 4.52 Billion by 2030 |
| Growth Rate | CAGR of 5.7% From 2021 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
Competitive Intelligence
The report provides an understanding of the market composition and explains the role of established players and regional contributors. It is essential for the market players to make calculative moves and focus on client acquisition and retention. The detailed company profiles will provide the necessary intelligence to the reader. In order to maintain their share, the market players are focusing on strategies such as cross-border expansion, product differentiation and so on.
Some of the prominent players in the global neurovascular devices market are listed as below:
- Medtronic
- MicroPort Scientific Corporation
- Penumbra, Inc.
- Stryker Corporation
- Johnson & Johnson Services, Inc.
- MicroVention, Inc.
- Codman Neuro
North America dominated the global neurovascular devices market, accounting for around 27% of the market share in 2020. The increasing prevalence of neurological disorders and growing geriatric population in US is boosting the growth of the region. According to the CDC, around 16.7% of the people across the globe will have a brain stroke. As per the CDC, over 795,000 people have stroke in US every year.Around 140,000 deaths in US every year are caused by strokes. It is also considered to be the second most prominent causes of death. Furthermore, presence of developed healthcare infrastructure in the region, increased healthcare expenditure, and increased awareness regarding neurological disorders are the major factors that boost the growth of the market in this region.
Asia Pacific is estimated to be the fastest-growing market during the forecast period. The rising government expenditure for developing sophisticated healthcare infrastructure in the region is expected to drive the growth of the market in the upcoming future. The rising efforts by the government and various NGOs in spreading the awareness regarding neurological disorders is fostering the adoption of various neurovascular devices. Moreover the presence of huge population, rising expenditure on healthcare, and increasing disposable income is expected to boost the neurovascular devices market in Asia Pacific region.
However, the lack of awareness among the population regarding the neurological disorders and neurovascular devices in the developing and underdeveloped regions may hamper the growth of the market. Furthermore, the lack of proper healthcare infrastructure in the underdeveloped markets restricts the growth of the market.
The rising developmental strategies adopted by the market players is expected to provide lucrative growth opportunities in the forthcoming years. The rising investment in the research and development in the field of neurology is encouraging the development of innovative and efficient neurovascular devices.
Based on the device, the cerebral embolization & aneurysm coiling devices segment dominated the global neurovascular devices market, accounting for around 38% of the market share in 2020. The increasing prevalence of various neurological disorders such as Arteriovenous Malformations, brain aneurysm, and strokes among the population is the major factor that boosts the growth of this segment.According to the CDC, there were around 15.2 million out of 56.9 deaths registered globally, due to stroke, in 2018. The most common type of stroke recoded was the Acute Ischemic Stroke. As per the data provided by the NHS England, 1 in 12,500 people suffers from ruptured brain aneurysm each year and approximately 3% of the people in UK is suffering from cerebral aneurysm.
Based on the application, the stroke segment dominated the global neurovascular devices market, accounting for over 57% of the market share in 2020. This can be attributed to the increased prevalence of strokes among the global population. As per the CDC, over 795,000 people have stroke in US every year and it accounts for around 140,000 deaths in US every year.The new product launches related to the stroke solutions is boosting the market growth. For instance, in September 2020, CERENOVOUS introduced CERENOVOUS Stroke Solution that aids the doctors in clot removal procedure.
Segments Covered in the Report
By Device
- Cerebral Angioplasty & Stenting Systems
- Support Devices
- Cerebral Embolization & Aneurysm Coiling Devices
- Neurothrombectomy Devices
By Application
- Cerebral Aneurysm
- Cerebral Artery Stenosis
- Stroke
- Others
Regional Segmentation
– North America (U.S. and Canada)
– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
– Latin America (Brazil and Rest of Latin America)
– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Neurovascular Devices Market
5.1. COVID-19 Landscape: Neurovascular Devices Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Neurovascular Devices Market, By Device
8.1. Neurovascular Devices Market, by Device Type, 2021-2030
8.1.1. Cerebral Angioplasty & Stenting Systems
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Support Devices
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Cerebral Embolization & Aneurysm Coiling Devices
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Neurothrombectomy Devices
8.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Neurovascular Devices Market, By Application
9.1. Neurovascular Devices Market, by Application, 2021-2030
9.1.1. Cerebral Aneurysm
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Cerebral Artery Stenosis
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Stroke
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Neurovascular Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Device (2019-2030)
10.1.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Device (2019-2030)
10.1.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Device (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Device (2019-2030)
10.2.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Device (2019-2030)
10.2.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Device (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Device (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Device (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Device (2019-2030)
10.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Device (2019-2030)
10.3.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Device (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Device (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Device (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Device (2019-2030)
10.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Device (2019-2030)
10.4.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Device (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Device (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Device (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Device (2019-2030)
10.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Device (2019-2030)
10.5.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Device (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
Chapter 11. Company Profiles
11.1. Medtronic
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. MicroPort Scientific Corporation
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Penumbra, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Stryker Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Johnson & Johnson Services, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. MicroVention, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Codman Neuro
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global neurovascular devices market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for neurovascular devices are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1391
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
